1/9 @MSF is appalled by the @US_FDA’s move to grant ‘orphan drug’ status to @GileadSciences #remdesivir ⁠—a potential treatment for #Covid19Out This decision will SIGNIFICANTLY hamper efforts to make this potentially key drug widely available and...

Medicines shouldn’t be a luxury